Related references
Note: Only part of the references are listed.Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
Florian Langer et al.
HAMOSTASEOLOGIE (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis
Stephan Nopp et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome
Elan Mohanty et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2019)
German S3 guideline for the prevention of venous thromboembolism updated
Sylvia Haas et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2016)